Athersys ROCE Ratio 2011-2026 | ATHX

Annual ROCE Ratio Athersys

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-531.85	-213.09	-157.79	-55.48	-141.57	-128.91	-84.28	-120.75	-82.02	-69.19	-166.41

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
-55.48	-531.85	-159.21

Quarterly ROCE Ratio Athersys

2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
180.34	259.58	431.55	-6981.96	-7114.38	-7270.26	-7549.65	-329.14	-266.61	-282.49	-268.26	-249.77	-222.79	-204.66	-188.74	-195.47	-179.36	-149.46	-91.27	-58.09	-87.83	-96.05	-138.81	-142.38	-141.43	-165.64	-203.64	-60.67	-94.63	-73.03	-43.57	-105.88	-140.66	-141.48	-140.69	-105.02	-133.29	-126.78	-123.07	-93.96	-114.95	-107.66	-94.34	-59.36	-102.64	-124.94	-154.62	-130.23	-43.29	-47.52	-39.42

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
431.55	-7549.65	-668.79

ROCE Ratio of other stocks in the Biotechnology industry

Issuer	ROCE Ratio	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	2.89	-	2.43 %	$ 254 M	Germany
Acer Therapeutics ACER	146.85	-	2.71 %	$ 14 M	USA
Alexion Pharmaceuticals, Inc. ALXN	17.36	-	-	$ 40.3 B	USA
AgeX Therapeutics AGE	-180.78	-	-10.17 %	$ 12.2 K	USA
Biophytis SA BPTS	-325.06	-	-13.47 %	$ 169 M	France
Aeglea BioTherapeutics AGLE	-29.3	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	-60.13	-	-	$ 26.5 M	USA
EyeGate Pharmaceuticals, Inc. EYEG	-61.36	-	-1.52 %	$ 24.7 M	USA
Midatech Pharma plc MTP	-337.43	-	-18.52 %	$ 27.3 M	Britain
Black Diamond Therapeutics BDTX	-94.59	$ 2.38	-3.64 %	$ 131 M	USA
ARCA biopharma ABIO	-23.06	-	1052.0 %	$ 415 M	USA
Acorda Therapeutics ACOR	167.74	-	-24.86 %	$ 820 K	USA
Acasti Pharma ACST	-25.04	-	4.01 %	$ 150 M	Canada
Adverum Biotechnologies ADVM	-196.79	-	-	$ 86.2 M	USA
Институт стволовых клеток человека ISKJ	15.18	-	-	-	Russia
AIkido Pharma AIKI	-28.92	-	1.93 %	$ 17.4 M	USA
Akero Therapeutics AKRO	-38.05	-	-	$ 3.67 B	USA
Akouos AKUS	-37.16	-	0.23 %	$ 488 M	USA
Albireo Pharma ALBO	-70.32	-	-0.23 %	$ 916 M	USA
Alector ALEC	-509.01	$ 2.1	-13.79 %	$ 216 M	USA
Allena Pharmaceuticals ALNA	-252.54	-	3.16 %	$ 1.9 M	USA
Aileron Therapeutics ALRN	-119.71	-	10.36 %	$ 9.8 M	USA
AlloVir ALVR	-57.76	-	4.14 %	$ 49.1 M	USA
Alpine Immune Sciences ALPN	-32.41	-	-	$ 2.17 B	USA
Aeterna Zentaris AEZS	-29.95	-	5.93 %	$ 314 M	Canada
Ampio Pharmaceuticals AMPE	-75.24	-	-11.43 %	$ 502 K	USA
Applied Molecular Transport AMTI	-209.11	-	-	$ 10.1 M	USA
Aravive ARAV	-664.7	-	-13.39 %	$ 1.45 M	USA
Aptose Biosciences APTO	-46.69	-	-45.71 %	$ 1.2 M	Canada
Aptinyx APTX	-163.42	-	-39.0 %	$ 4.57 M	USA
Athira Pharma ATHA	-225.02	-	-	$ 269 M	USA
Aridis Pharmaceuticals ARDS	123.77	-	17.91 %	$ 11.1 M	USA
Altimmune ALT	-80.08	$ 4.2	-2.67 %	$ 298 M	USA
Arena Pharmaceuticals ARNA	-92.73	-	-6.81 %	$ 3.04 B	USA
CureVac N.V. CVAC	-51.5	-	-	$ 867 M	Germany
Avenue Therapeutics ATXI	-403.4	-	-52.27 %	$ 4.45 M	USA
Axcella Health AXLA	-1848.9	-	-16.42 %	$ 249 M	USA
AstraZeneca PLC AZN	11.12	-	-	$ 96.9 B	Britain
AVEO Pharmaceuticals AVEO	-108.03	-	-	$ 521 M	USA
Atreca BCEL	-34.9	-	-11.76 %	$ 5.79 M	USA
AVROBIO AVRO	10.76	-	1083.1 %	$ 745 M	USA
Apellis Pharmaceuticals APLS	14.97	$ 20.61	-1.67 %	$ 2.6 B	USA
Agenus AGEN	99.51	$ 3.33	-	$ 1.19 M	USA
Ayala Pharmaceuticals AYLA	3412.47	-	-	$ 7.46 M	Israel
Agios Pharmaceuticals AGIO	-39.57	$ 28.87	-4.5 %	$ 1.67 B	USA
bluebird bio BLUE	-125.56	-	-	$ 546 M	USA
Brickell Biotech BBI	-64.05	-	-5.38 %	$ 6.06 M	USA
Advaxis ADXS	429.74	-	-9.65 %	$ 45.9 M	USA